Siga Technologies (SIGA) Non-Current Debt (2012 - 2019)
Siga Technologies' (SIGA) quarterly Non-Current Debt came in at $78.9 million in Q3 2019, up 6.04% on a YoY basis from $74.4 million in Q3 2018, and up 1.46% quarter-over-quarter from $77.8 million in Q2 2019.
Analysis
Siga Technologies (SIGA) Non-Current Debt (2012 - 2019) Analysis & Trends
Siga Technologies (SIGA) has reported Non-Current Debt for 7 consecutive years, with $78.9 million the latest figure, recorded in Q3 2019.
- For the quarter ending Q3 2019, Non-Current Debt rose 6.04% year-over-year to $78.9 million; the trailing twelve-month figure through Sep 2019 stood at $78.9 million (up 6.04% YoY), and the FY2018 full-year result was $75.5 million, up 6.33% from the prior year.
- Non-Current Debt improved to $78.9 million in Q3 2019 per SIGA's latest filing, from $77.8 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $78.9 million in Q3 2019 and bottomed at $66.6 million in Q4 2016.
- Historically, Non-Current Debt has averaged $72.7 million across 4 years, with a median of $72.7 million in 2018.
- The sharpest annual moves came in 2017 and 2019: Non-Current Debt increased 6.76% in 2017, then climbed 6.04% in 2019.
- Over 4 years, Non-Current Debt stood at $66.6 million in 2016, then advanced by 6.76% to $71.1 million in 2017, then gained by 6.33% to $75.5 million in 2018, then gained by 4.45% to $78.9 million in 2019.
- According to Business Quant data, Non-Current Debt over the past three periods registered $78.9 million, $77.8 million, and $76.7 million for Q3 2019, Q2 2019, and Q1 2019 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 60.50 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 17.02 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2019 | 78.91 Mn |
| Jun 30, 2019 | 77.78 Mn |
| Mar 31, 2019 | 76.66 Mn |
| Dec 31, 2018 | 75.55 Mn |
| Sep 30, 2018 | 74.41 Mn |
| Jun 30, 2018 | 73.28 Mn |
| Mar 31, 2018 | 72.16 Mn |
| Dec 31, 2017 | 71.05 Mn |
| Sep 30, 2017 | 69.92 Mn |
| Jun 30, 2017 | 68.78 Mn |
| Mar 31, 2017 | 67.66 Mn |
| Dec 31, 2016 | 66.55 Mn |
| Dec 31, 2014 | 1.99 Mn |
| Sep 30, 2014 | 2.50 Mn |
| Jun 30, 2014 | 997,693.00 |
| Mar 31, 2014 | 1.49 Mn |
| Dec 31, 2013 | 1.99 Mn |
| Sep 30, 2013 | 2.48 Mn |
| Jun 30, 2013 | 2.98 Mn |
| Mar 31, 2013 | 3.47 Mn |